









市場
/
株式
/
nasdaq-neo
/

Neogenomics Inc

NEO

10.420USD

+0.020+0.19%

終値 11/11, 16:00（ET）15分遅れの株価

1.34B時価総額

損失額直近12ヶ月PER



Neogenomics Inc

10.420

+0.020+0.19%

概要企業名金融分析

概要

企業名

金融

分析

詳細情報 Neogenomics Inc 企業名

NeoGenomics, Inc. provides a range of oncology diagnostic testing and consultative services which includes technical laboratory services. The Company offers professional interpretation of laboratory test results by licensed physicians who specialize in pathology and oncology. Its segments include Clinical Services and Advanced Diagnostics. The Clinical Services segment consists of clinical cancer testing; interpretation and consultative services; molecular and NGS testing, and comprehensive technical and professional services offering. Its Clinical Services customers include community-based pathology and oncology practices, hospital pathology labs, reference labs, and academic centers. The Advanced Diagnostics segment consist of clinical trials and research, validation laboratory services, and informatics. Its Advanced Diagnostics customers include pharmaceutical companies to whom it provides testing and other services to support their research studies and clinical trials.

Neogenomics Incの企業情報



企業コードNEO

会社名Neogenomics Inc

上場日Dec 10, 2012

最高経営責任者「CEO」Mr. Antony P. Zook

従業員数2200

証券種類Ordinary Share

決算期末Dec 10

本社所在地9490 Neogenomics Way

都市FORT MYERS

証券取引所NASDAQ Capital Market Consolidated

国United States of America

郵便番号33912

電話番号12397680600

ウェブサイトhttps://neogenomics.com/

企業コードNEO

上場日Dec 10, 2012

最高経営責任者「CEO」Mr. Antony P. Zook

Neogenomics Incの経営陣



会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Jeffrey Scott (Jeff) Sherman

Chief Financial Officer

186.66K

+12.00%

Mr. Warren Stone

President, Chief Operating Officer

108.28K

+19.26%

Mr. Stephen Michael Kanovsky

Independent Director

52.34K

+30.57%

Dr. Neil Gunn

Independent Director

28.10K

+77.33%

Ms. Felicia Williams

Independent Director

7.16K

Ms. Lynn A. Tetrault, J.D.

Independent Chairman of the Board

Dr. Alison L. Hannah, M.D.

Independent Director

Mr. Gregory Aunan

Chief Accounting Officer

Ms. Alicia Olivo

Executive Vice President, General Counsel & Business Development

Mr. Michael A. Kelly

Lead Independent Director

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Jeffrey Scott (Jeff) Sherman

Chief Financial Officer

186.66K

+12.00%

Mr. Warren Stone

President, Chief Operating Officer

108.28K

+19.26%

Mr. Stephen Michael Kanovsky

Independent Director

52.34K

+30.57%

Dr. Neil Gunn

Independent Director

28.10K

+77.33%

Ms. Felicia Williams

Independent Director

7.16K

Ms. Lynn A. Tetrault, J.D.

Independent Chairman of the Board

収益内訳

通貨: USD更新時刻: Mon, Oct 6

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

Clinical Services-Client direct billing

131.16M

72.33%

Clinical Services-Commercial Insurance

28.77M

15.86%

Clinical Services-Medicare and Medicaid

21.39M

11.79%

Clinical Services-Self-Pay

20.00K

0.01%

データなし

事業別

地域別

事業別USD

会社名

収益

比率

Clinical Services-Client direct billing

131.16M

72.33%

Clinical Services-Commercial Insurance

28.77M

15.86%

Clinical Services-Medicare and Medicaid

21.39M

11.79%

Clinical Services-Self-Pay

20.00K

0.01%

株主

更新時刻: Fri, Oct 31

株主統計

種類

株主統計

比率

BlackRock Institutional Trust Company, N.A.

13.73%

The Vanguard Group, Inc.

10.72%

Greenhouse Funds LLLP

5.74%

First Light Asset Management, LLC

5.29%

State Street Investment Management (US)

3.95%

他の

60.56%

株主統計

比率

BlackRock Institutional Trust Company, N.A.

13.73%

The Vanguard Group, Inc.

10.72%

Greenhouse Funds LLLP

5.74%

First Light Asset Management, LLC

5.29%

State Street Investment Management (US)

3.95%

他の

60.56%

種類

株主統計

比率

Investment Advisor

49.75%

Investment Advisor/Hedge Fund

30.92%

Hedge Fund

13.93%

Research Firm

2.37%

Individual Investor

1.29%

Pension Fund

1.20%

Bank and Trust

0.59%

Sovereign Wealth Fund

0.09%

Family Office

0.05%

機関投資家保有株



更新時刻: Wed, Oct 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q3

568

127.88M

98.83%

-9.78M

2025Q2

571

126.82M

98.17%

-12.95M

2025Q1

596

131.44M

102.13%

-4.71M

2024Q4

585

127.59M

99.32%

-7.82M

2024Q3

589

129.38M

100.96%

-8.76M

2024Q2

597

131.21M

102.74%

-9.36M

2024Q1

633

132.83M

104.04%

-13.13M

2023Q4

672

130.90M

102.70%

-12.18M

2023Q3

691

124.98M

98.00%

-16.78M

2023Q2

691

121.76M

95.45%

-23.63M

詳細を見る

株主動向



会社名

保有株式数

比率

変動額

変動率

日付

BlackRock Institutional Trust Company, N.A.

17.77M

13.76%

-516.86K

-2.83%

Jun 30, 2025

The Vanguard Group, Inc.

14.10M

10.92%

-126.36K

-0.89%

Jun 30, 2025

Greenhouse Funds LLLP

7.43M

5.75%

+2.72M

+57.83%

Jun 30, 2025

First Light Asset Management, LLC

6.85M

5.3%

+803.61K

+13.30%

Jun 30, 2025

State Street Investment Management (US)

5.11M

3.96%

+21.77K

+0.43%

Jun 30, 2025

Macquarie Investment Management

4.81M

3.72%

+130.73K

+2.80%

Jun 30, 2025

Dimensional Fund Advisors, L.P.

4.29M

3.32%

+448.53K

+11.66%

Jun 30, 2025

Schroder Investment Management North America Inc.

3.72M

2.88%

-587.33K

-13.63%

Jun 30, 2025

American Century Investment Management, Inc.

3.52M

2.72%

+197.88K

+5.96%

Jun 30, 2025

Millennium Management LLC

3.32M

2.57%

-3.40M

-50.63%

Jun 30, 2025

詳細を見る

配当金



過去5年間の配当金総支払額は 0.00 米ドルである。

日付

配当金

権利確定日

支払日

配当落ち日

データなし

株式分割



日付

種類

比率

データなし

日付

種類

比率

データなし

KeyAI



Neogenomics Inc

詳細情報 Neogenomics Inc 企業名

Neogenomics Incの企業情報

Neogenomics Incの経営陣

収益内訳

株主

機関投資家保有株

株主動向

関連ETF

配当金

株式分割